IntroductionMalignant peritoneal mesothelioma is a rare cancer with poor patient survival. Female gender has been identified as a positive prognostic factor.
Recently, it has been suggested that the expression of estrogen receptor in malignant mesothelioma leads to tumor suppression and a better prognosis.Case presentationWe report the case of a 48-year-old Caucasian woman who is alive and disease-free seven years after the initial diagnosis and treatment of malignant peritoneal mesothelioma.
Conclusion: This patient's long survival may be attributable to a combination of factors, including minimal disease, complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy plus the estrogen receptor beta positivity of the tumor.
Author: Krishna PillaiJaved AkhterMohammad PourgholamiDavid Morris
Credits/Source: Journal of Medical Case Reports 2011, 5:36
No comments:
Post a Comment